| Company Name: |
BOC Sciences |
| Tel: |
16314854226 |
| Email: |
info@bocsci.com |
| Company Name: |
BOC Sciences |
| Tel: |
16314854226; +8616314854226 |
| Email: |
inquiry@bocsci.com |
| Company Name: |
TargetMol |
| Tel: |
400-821-0310 15002144251 |
| Email: |
xuexiang.shao@tsbiochem.com |
|
| | CAY10509 Basic information |
| Product Name: | CAY10509 | | Synonyms: | CAY10509;WXWNDRIOPFNYII-AJGRXUDCSA-N;Cyclopentaneheptanoic acid, 2-[(3R)-4-[(2-fluorophenyl)thio]-3-hydroxybutyl]-3,5-dihydroxy-, methyl ester, (1R,2R,3R,5S)- | | CAS: | 1245699-47-1 | | MF: | C23H35FO5S | | MW: | 442.58 | | EINECS: | | | Product Categories: | | | Mol File: | 1245699-47-1.mol |  |
| | CAY10509 Chemical Properties |
| solubility | DMF: 50 mg/ml; DMSO: 50 mg/ml; Ethanol: 100 mg/ml; PBS (pH 7.2): 0.25 mg/ml |
| | CAY10509 Usage And Synthesis |
| Description | The actions of many clinical prostaglandins, including those used for estrous synchronization and for reduction of intraocular pressure, are mediated through the FP receptor. CAY10509 is an analog of PGF2α containing a thio-fluorobenzene substituent in the lower side chain. CAY10509 has an IC50 of about 30 nM when tested for binding to the recombinant human FP receptor. | | Uses | CAY10509 is a PGF2α analog and an inhibitor of the FP receptor with an IC50 of 30 nM. CAY10509 is promising for studying physiological regulatory mechanisms related to prostaglandins[1]. | | IC 50 | FP: 30 nM (IC50) | | References | [1] Negishi M, et al. Prostanoid receptors and their biological actions. Prog Lipid Res. 1993;32(4):417-34. DOI:10.1016/0163-7827(93)90017-q |
| | CAY10509 Preparation Products And Raw materials |
|